On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing
On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing
11月22日，oncternal therapeutics宣佈納斯達克計劃在12月3日將其股票除牌，納斯達克將該公司分類爲「公衆空殼」，這是在其決定裁員和探索戰略替代方案後做出的決定-申報
納斯達克將向美國證券交易委員會提交除牌通知。oncternal已表示將不對該決定提出上訴。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間